AHA Statement on DC Circuit Court of Appeals Decision on Mandated Disclosure of Negotiated Rates

 Melinda Hatton
General Counsel
American Hospital Association

December 29, 2020

America’s hospitals and health systems support the goal of increasing price transparency by making patient out-of-pocket cost estimates easier to access and understand. Our focus remains on providing patients with the knowledge they actually need to make informed decisions about their health care. That is why we are disappointed in today’s decision to uphold the District Court rejection of hospitals’ challenge to the rule. Further, the decision to decline a stay in enforcement ignores the overwhelming burden of the pandemic on hospitals.

The AHA continues to believe that the disclosure of privately negotiated rates does nothing to help patients understand what they will actually pay for treatment and will create widespread confusion for them. We also believe it will accelerate anticompetitive behavior among commercial health insurers and hinder innovations in value-based care delivery. Lastly, the requirement imposes significant costs on care providers at a time when scarce resources are needed to fight COVID-19 and save lives. For these reasons, the AHA has urged the incoming administration to evaluate whether the rule should be revised and to exercise enforcement discretion for the duration of the public health emergency.

We are reviewing the decision carefully to determine next steps.


Contact:       Sean Barry, (202) 626-2306
                     Marie Johnson, (202) 626-2351

Related Resources

Letter the AHA sent to Senators Grassley and Durbin in support of S. 2304, Drug-Price Transparency for Consumers Act of 2021. The bill will allow HHS to…
Special Bulletin
The United States Supreme Court this morning rejected the third major challenge to the Affordable Care Act, holding in a 7-2 decision that the challengers did…
The hospital price transparency rule took effect Jan. 1, 2021. CMS verified for the AHA that the agency has begun proactive audits of hospital websites and a…
AHA urges the Centers for Medicare & Medicaid Services to align the Hospital Price Transparency Rule with new transparency requirements included in the No…
Fact Sheets
For more than 25 years, the 340B Drug Pricing Program has provided financial help to hospitals serving vulnerable communities to manage rising prescription…
AHA letter urging HHS to exercise enforcement discretion with respect to the hospital price transparency rule.